A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine

NCT03483116 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

711

Enrollment

OTHER

Sponsor class

Conditions

Rotavirus Infections

Interventions

BIOLOGICAL: RV3-BB
BIOLOGICAL: Placebo

Sponsor

Murdoch Childrens Research Institute